Bellicum Pharmaceuticals to Report Second Quarter 2017 Financial Results and Host Conference Call and Webcast on August 8, 2017 Read more about Bellicum Pharmaceuticals to Report Second Quarter 2017 Financial Results and Host Conference Call and Webcast on August 8, 2017
Bellicum Reports Clinical Results of BPX-501 in Pediatric Leukemias at the 22nd Congress of the European Hematology Association Read more about Bellicum Reports Clinical Results of BPX-501 in Pediatric Leukemias at the 22nd Congress of the European Hematology Association
Bellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European Hematology Association Read more about Bellicum Announces Clinical Data on BPX-501 at Presidential Symposium of the 22nd Congress of the European Hematology Association
Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference Read more about Bellicum Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Bellicum Announces Clinical Presentations at the 22nd Congress of the European Hematology Association Read more about Bellicum Announces Clinical Presentations at the 22nd Congress of the European Hematology Association
Bellicum Pharmaceuticals Announces Management Changes Read more about Bellicum Pharmaceuticals Announces Management Changes
Bellicum Pharmaceuticals Reports First Quarter 2017 Financial Results Read more about Bellicum Pharmaceuticals Reports First Quarter 2017 Financial Results
Bellicum Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care Conference Read more about Bellicum Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care Conference
Bellicum Pharmaceuticals Announces Late-Breaking Presentation of Dual-Switch CAR-T / TCR Technology at AACR Read more about Bellicum Pharmaceuticals Announces Late-Breaking Presentation of Dual-Switch CAR-T / TCR Technology at AACR
Bellicum Pharmaceuticals Announces Closing of Public Offering Read more about Bellicum Pharmaceuticals Announces Closing of Public Offering